Inger Lise Gade: Clinical Trials

2 trials sponsored by Inger Lise Gade, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. .

Follow Inger Lise Gade: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate
Covid19, Corona Virus Infection
CompletedInger Lise Gade282020-09-192022-02-15
Non-invasive Diagnosis of Invasive Pulmonary Aspergillosis by Use of Biomarkers in Exhaled Breath Condensate
Aspergillus specific proteins in exhaled breath condensate (EBC), Pneumocystis jirovecii DNA in exhaled breath condensate (EBC) - Aspergillosis Pneumonia, Pneumocystis Pneumonia
CompletedInger Lise Gade1012020-04-172024-02-13

Conditions studied

COVID-19 (1)  ·  Coronavirus Infections (1)  ·  Pneumonia, Pneumocystis (1)

Countries

Denmark (2)

Top investigators

Inger L Gade, MD PhD (1)  ·  Inger L Gade, MD, PhD (1)

Results publications

PMID 40341493